PEGS Europe: Protein & Antibody Engineering Summit - 2025 - In Person

PEGS Europe: Protein & Antibody Engineering Summit - 2025 - In Person
€2692.47

Selected Conference Pricing
Premium Package Commercial - Early - Registration Rate Until September 12, 2025€2239

Selected Conference Programs
C2A: Antibody-Based TherapiesTargets
C2C: Antibodies Against Membrane Protein TargetsTargets
C8B: Engineering Antibody-Drug ConjugatesOncology

Selected Discounts
Poster Discount€50 off

Track Poster Detail
Track SelectedC2B: Emerging Targets for Oncology & Beyond
Poster TitleTCX-201, a novel ADC targeting a specific tumor-associated carbohydrate antigen (TACA) with excellent preclinical efficacy, PK and safety profile in solid tumor models.